DE60203878D1 - Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen - Google Patents

Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Info

Publication number
DE60203878D1
DE60203878D1 DE60203878T DE60203878T DE60203878D1 DE 60203878 D1 DE60203878 D1 DE 60203878D1 DE 60203878 T DE60203878 T DE 60203878T DE 60203878 T DE60203878 T DE 60203878T DE 60203878 D1 DE60203878 D1 DE 60203878D1
Authority
DE
Germany
Prior art keywords
bovine
pain
prevention
treatment
stomach diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60203878T
Other languages
English (en)
Other versions
DE60203878T2 (de
Inventor
Maria Chovet
Laurent Diop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE60203878D1 publication Critical patent/DE60203878D1/de
Publication of DE60203878T2 publication Critical patent/DE60203878T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60203878T 2001-01-26 2002-01-25 Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen Expired - Fee Related DE60203878T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01400214A EP1226820A1 (de) 2001-01-26 2001-01-26 Verwendung von bicyclische Aminosäuren zur Prophylaxe und Behandlung von Eingeweideschmerzen und gastrointestinalen Erkrankungen
EP01400214 2001-01-26
PCT/EP2002/001351 WO2002058680A2 (en) 2001-01-26 2002-01-25 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders

Publications (2)

Publication Number Publication Date
DE60203878D1 true DE60203878D1 (de) 2005-06-02
DE60203878T2 DE60203878T2 (de) 2006-02-16

Family

ID=8182608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203878T Expired - Fee Related DE60203878T2 (de) 2001-01-26 2002-01-25 Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Country Status (22)

Country Link
US (2) US6784208B2 (de)
EP (3) EP1226820A1 (de)
JP (2) JP2004517147A (de)
KR (1) KR20030070140A (de)
CN (1) CN1610544A (de)
AR (1) AR036009A1 (de)
AT (1) ATE293968T1 (de)
BR (1) BR0206687A (de)
CA (1) CA2435950A1 (de)
DE (1) DE60203878T2 (de)
DK (1) DK1357910T3 (de)
ES (1) ES2240686T3 (de)
IL (2) IL164012A0 (de)
MX (1) MXPA03006723A (de)
NZ (1) NZ526625A (de)
PE (1) PE20020832A1 (de)
PL (1) PL363354A1 (de)
PT (1) PT1357910E (de)
SI (1) SI1357910T1 (de)
TW (1) TWI223593B (de)
WO (1) WO2002058680A2 (de)
ZA (2) ZA200305590B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006396B1 (ru) * 2001-04-19 2005-12-29 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл Эл Си Конденсированные бициклические аминокислоты
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
DE69834204T2 (de) * 1997-10-27 2007-03-29 Warner-Lambert Co. Llc Zyklische aminosäuren und deren derivate als arzneimittel
EP1031350A1 (de) * 1999-02-23 2000-08-30 Warner-Lambert Company Verwendung eines Gabapentin-Analogen zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Eingeweideschmerzen
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
EA006396B1 (ru) * 2001-04-19 2005-12-29 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл Эл Си Конденсированные бициклические аминокислоты

Also Published As

Publication number Publication date
BR0206687A (pt) 2004-02-03
JP2005015492A (ja) 2005-01-20
DE60203878T2 (de) 2006-02-16
KR20030070140A (ko) 2003-08-27
JP2004517147A (ja) 2004-06-10
EP1514541A1 (de) 2005-03-16
SI1357910T1 (de) 2005-08-31
US20020161047A1 (en) 2002-10-31
EP1357910A2 (de) 2003-11-05
ZA200305590B (en) 2004-10-18
US20040266876A1 (en) 2004-12-30
PT1357910E (pt) 2005-08-31
EP1357910B1 (de) 2005-04-27
EP1226820A1 (de) 2002-07-31
NZ526625A (en) 2004-12-24
PE20020832A1 (es) 2002-10-03
DK1357910T3 (da) 2005-08-08
ES2240686T3 (es) 2005-10-16
IL164012A0 (en) 2005-12-18
AR036009A1 (es) 2004-08-04
PL363354A1 (en) 2004-11-15
CN1610544A (zh) 2005-04-27
MXPA03006723A (es) 2003-10-24
ZA200407412B (en) 2005-06-29
CA2435950A1 (en) 2002-08-01
WO2002058680A2 (en) 2002-08-01
US6784208B2 (en) 2004-08-31
TWI223593B (en) 2004-11-11
ATE293968T1 (de) 2005-05-15
WO2002058680A3 (en) 2002-09-19
IL156667A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
DE60231601D1 (de) Einrichtung und verfahren zur behandlung
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
ATE369133T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60224163D1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE323500T1 (de) Verfahren und zusammensetzung zur behandlung von verzögerten allergischen reaktionen und entzündungskrankheiten
DE60317061D1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60335293D1 (de) Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
DE60027290D1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE60312505D1 (de) Injektion aus ixeris sonchifolia zur behandlung von kardiozerebralen gefässerkrankungen und funduserkrankungen sowie herstellungsverfahren dafür
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee